Fibromyalgia syndrome: What's new in 2009?;Actualités de la fibromyalgie

Revue du Rhumatisme (Edition Francaise)

Volumn 76, Issue 6, 2009, Pages 529-536

  Laroche, Françoise ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Fibromyalgia; New approaches and treatments; Rheumatic painful condition

Indexed keywords

EID: 67649256055     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rhum.2009.02.001     Document Type: Short Survey

References (47)

1. Wolfe F., Smythe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Commitee. Arthritis Rheum 33 (1990) 160-172
2. Katz R.S., Wolfe F., Michaud K., et al. Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease. J Rheumatol 30 (2003) 369-378
3. Mease P.J. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures and treatment. J Rheumatol 75 (2005) 6-21
4. Mease P.J., Clauw D.J., Arnold L.M., et al. Fibromyalgia syndrome. J Rheumatol 32 (2005) 2270-2277
5. Katz R.S., Wolfe F., Michaud K., et al. Fibromyalgia diagnosis. A comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 54 (2006) 169-176
6. Burckhardt C., Goldenberg D.L., Crofford L., et al. Fibromyalgia syndrome pain management guideline panel 2002-2005. Guideline for the management of fibromyalgia syndrome pain in adults and children (2005), American Pain Society (APS), Glenview (IL) 109 p. [Clinical practice guideline; No. 4]
7. Fitzcharles M.A., and Boulos P. Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology (Oxford) 42 (2003) 263-267
8. Staud R., and Smitherman M.L. Peripheral and central sensitization in fibromyalgia syndrome: pathogenetic role. Current Pain Headache Rep 6 (2002) 259-266
9. White K.P., and Thompson J. Fibromyalgia syndrome in an Amish community: a controlled study to determine disease and symptom prevalence. J Rheumatol 30 (2003) 1835-1844
10. Ozgocmen S. New strategies in evaluation of therapeutic efficacy in fibromyalgia syndrome. Curr Pharm Des 12 (2006) 67-71
11. Bennett R.M. The fibromyalgia impact questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23 (2005) S154-162
12. Perrot S., Dumont D., Guillemin F., et al. For the French group of quality of life research. Quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the fibromyalgia impact questionnaire. J Rheumatol 30 (2003) 1054-1059
13. Mease P., Arnold L.M., Bennett R., et al. Fibromyalgia syndrome. J Rheumatol 34 (2007) 1415-1425
14. Gracely R.H., Petzeke F., Wolf J.M., et al. Fonctional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46 (2002) 1333-1343
15. Adler G.K., and Geenen R. Hypothalamic-pituitary-adrenal and autonomic nervous system functioning in fibromyalgia. Rheum Dis Clin N Am 31 (2005) 187-202
16. McLean S.A., Williams D.A., Harris R.E., et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum 52 (2005) 3660-3669
17. Offenbaecher M., Bondy B., De Jonge S., et al. Possible association of fibromyalgia with a polymorphisme in serotonin transporter gene regulatory R region. Arthritis Rheum 50 (2004) 944-952
18. Kato K., Sullivan P.F., Evengard B., et al. Importance of genetic influences on chronic widespread pain. Arthritis Rheum 54 (2006) 1682-1686
19. Janicki P.K., Schuler G., Francis D., et al. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain. Anesth Analg 103 (2006) 1011-1017
20. Knaster J., Estlander A., Kalso E., et al. Psychiatric morbidity in chronic pain. IASP (2008) [Abstract PT 104]
21. Berger A., Dukes E., Martins S., et al. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract 61 (2007) 1498-1508
22. Sullivan M., Scott R., Bishop, et al. The pain catastrophyzing scale: development and validation. Psychol Assess 7 (1995) 524-532
23. Staud R., O'Brian E.M., Craggs J.G., et al. Fibromyalgia patients expect very high levels of symptom relief associated with a single rheumatology office visit. IASP (2008) [Abstract PF 093]
24. Hugues G., Martinez C., Myon E., et al. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 54 (2006) 177-183
25. Bennett R.M., Kamin M., Karim R., et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double blind, randomized, placebo-controlled study. Am J Med 114 (2003) 537-545
26. Carville S.F., Arendt-Nielsen S., Bliddal H., et al. Eular evidence-based recommandations for the management of fibromyalgia syndrome. Ann Rheum Dis 67 (2008) 536-541
27. LittleJohn G.O., and Guymer E.K. Fibromyalgia syndrome: which antidepressant drug should we choose?. Curr Pharm Des 12 (2006) 3-9
28. Ozerbil O., Okudan N., Gokbel H., et al. Comparison of the effects of two antidepressants on exercise performance of the female patients with fibromyalgia. Clin Rheumatol 3 (2005) 1-3
29. Goldenberg D.L., Burckhardt C., Crofford L., et al. Management of fibromyalgia syndrome. JAMA 292 (2004) 2388-2395
30. Gendreau R.M., Thorn M.D., Gendreau J.F., et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 32 (2005) 1975-1985
31. Vitton O., Gendreau M., Gendreau J., et al. A double blind placebo-controlled trial of minalcipran in the treatment of fibromyalgia. Hum Psychopharmacol 19 Suppl 1 (2004) S27-S35
32. Arnold L.M., Lu Y., Crofford L.J., et al. A double blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50 (2004) 2974-2984
33. Dwight M.M., Arnold L.M., O'Brien H., et al. An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics 39 (1998) 14-17
34. Crofford L.J., Mease P.J., Simpson S.L., et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREDOM): at 6 months, double-blind, placebo-controlled trial with pregabalin. Pain 136 (2008) 31
35. Arnold L.M., Goldenberg D.L., Stanford S.B., et al. Gabapentin in the treatment of fibromyalgia. A randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 56 (2007) 1336-1344
36. Holman A.J., and Myers R.R. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 52 (2005) 2495-2505
37. Morley S. RCTs of psychological treatments for chronic pain: progress and challenges. Pain 121 (2006) 171-172
38. Burckhardt C.S., Clarck S.R., Bennett R.M., et al. Multidisciplinary approaches for management of fibromyalgia. Curr Pharm Des 12 (2006) 59-66
39. van Koulil S., Effting M., Kraaimaat F.W., et al. Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions. Ann Rheum Dis 66 (2007) 571-581
40. Thieme K., Turk D., Flor H., et al. Responder criteria for operant and cognitive-behavioural treatment of fibromyalgia syndrome. Arthritis Rheum (Arthritis Care Res) 57 (2007) 830-836
41. McCracken L.M., MacKichan, Eccleston C., et al. Contextual cognitive-behavioral therapy for severely disabled chronic pain sufferers: effectiveness and clinically significant change. Eur J Pain 11 (2007) 314-322
42. Sephton S.E., Salmon P., Weissbecker I., et al. Mindfulness meditation alleviates depressive symptoms in women with fibromaylgia: results of a randomized clinical trial. Arthritis Rheum 15 (2007) 77-85
43. Cedraschi C., Desmeules J., Rapiti E., et al. Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management. Ann Rheum Dis 63 (2004) 290-296
44. Busch A.J., Barber K.A., Overend T.J., et al. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev 4 (2007) CD003786
45. Mayhew E., and Ernst E. Acupuncture for fibromyalgia. A systematic review of randomyzed clinical trial. Rheumatology 46 (2007) 801-804
46. Passard A., Attal N., Benadhira R., et al. Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic pain in fibromyalgia. Brain 130 (2007) 2661-2670
47. Dworkin R.H., Turk D., Wyrwich K.W., et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9 (2008) 105-121